Discover how sugar quietly damages your liver through dangerous mechanisms. Learn about fatty liver disease, inflammation, ...

SUNRISE-PD is a Phase 2b, multicenter, randomized, double-blind, placebo-controlled trial with a hybrid decentralized design that will last 20 weeks from the initial screening phase to the safety ...

Fact checked by Nick Blackmer For years, I trusted the words, “You’re healthy,” at my annual physicals. As someone diagnosed ...

Cinnamon and honey before bed may support weight loss—but not magically. Here’s what science says about their true metabolic ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...

Udita Agarwal, an Indian nutritionist, shed 30 kg in 8 months without hitting the gym, relying on consistent, small lifestyle ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

CARDIFF, UNITED KINGDOM / ACCESS Newswire / June 18, 2025 / When it comes to type 1 diabetes, treating this chronic condition ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

Statins lower artery-clogging cholesterol and cut risks of cardiovascular disease, heart attacks and strokes. But are the drugs helpful if you have fatty liver disease, or can they be harmful? We ...